The member of the cyclic di-nucleotide family bis-(3', 5')-cyclic dimeric inosine monophosphate exerts potent activity as mucosal adjuvantLIBANOVA, Rimma; EBENSEN, Thomas; SCHULZE, Kai et al.Vaccine. 2010, Vol 28, Num 10, pp 2249-2258, issn 0264-410X, 10 p.Article

Induction of serum and mucosal FIV-specific immune responses by intranasal immunization with p24GagLEAVELL, Sarah; WRIGHT, Brittany; SCAPPINO, Lori et al.Vaccine. 2005, Vol 23, Num 12, pp 1471-1478, issn 0264-410X, 8 p.Article

Co-administration of cholera toxin and apple polyphenol extract as a novel and safe mucosal adjuvant strategyYOSHINO, Naoto; FUJIHASHI, Kohtaro; HAGIWARA, Yukari et al.Vaccine. 2009, Vol 27, Num 35, pp 4808-4817, issn 0264-410X, 10 p.Article

Enhancement of intranasal vaccination in mice with deglycosylated chain A ricin by LTR72, a novel mucosal adjuvantKENDE, Meir; DEL GIUDICE, Giuseppe; RIVERA, Noelia et al.Vaccine. 2006, Vol 24, Num 12, pp 2213-2221, issn 0264-410X, 9 p.Article

The mucosal adjuvanticity of the oligodeoxynucleotides containing a non-methylated CpG motif on BCG and diphtheria toxoidMAEYAMA, Jun-Ichi; KOMIYA, Takako; TAKAHASHI, Motohide et al.Vaccine. 2009, Vol 27, Num 8, pp 1166-1173, issn 0264-410X, 8 p.Article

An α-GalCer analogue with branched acyl chain enhances protective immune responses in a nasal influenza vaccineLEE, Yoon-Sook; LEE, Kyoo-A; LEE, Jae-Young et al.Vaccine. 2011, Vol 29, Num 3, pp 417-425, issn 0264-410X, 9 p.Article

Influenza vaccine with Surfacten, a modified pulmonary surfactant, induces systemic and mucosal immune responses without side effects in minipigsNISHINO, Maki; MIZUNO, Dai; KIMOTO, Takashi et al.Vaccine. 2009, Vol 27, Num 41, pp 5620-5627, issn 0264-410X, 8 p.Article

Bis-(3',5')-cyclic dimeric adenosine monophosphate: Strong Th1/Th2/Th17 promoting mucosal adjuvantEBENSEN, Thomas; LIBANOVA, Rimma; SCHULZE, Kai et al.Vaccine. 2011, Vol 29, Num 32, pp 5210-5220, issn 0264-410X, 11 p.Article

Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvantZHIWEI SUI; QUANJIAO CHEN; FANG FANG et al.Vaccine. 2010, Vol 28, Num 48, pp 7690-7698, issn 0264-410X, 9 p.Article

Reduction of nasal colonization of nontypeable Haemophilus influence following intranasal immunization with rLP4/rLP6/UspA2 proteins combined with aqueous formulation of RC529MASON, Kathryn W; DUZHANG ZHU; SCHEUER, Catherine A et al.Vaccine. 2004, Vol 22, Num 25-26, pp 3449-3456, issn 0264-410X, 8 p.Article

Induction of immune response to the 17 kDa OMPA Burkholderia cenocepacia polypeptide and protection against pulmonary infection in mice after nasal vaccination with an OMP nanoemulsion-based vaccineMAKIDON, P. E; KNOWLTON, J; GROOM, J. V et al.Medical microbiology and immunology. 2010, Vol 199, Num 2, pp 81-92, issn 0300-8584, 12 p.Article

A nasal vaccine comprising B-subunit derivative of Shiga toxin 2 for cross-protection against Shiga toxin types 1 and 2TSUJI, Takao; SHIMIZU, Takeshi; MORI, Hiroshi et al.Vaccine. 2008, Vol 26, Num 17, pp 2092-2099, issn 0264-410X, 8 p.Article

Intranasal immunization with influenza virus and Korean mistletoe lectin C (KML-C) induces heterosubtypic immunity in miceSEONG KYU SONG; MOLDOVEANU, Zina; NGUYEN, Huan H et al.Vaccine. 2007, Vol 25, Num 34, pp 6359-6366, issn 0264-410X, 8 p.Article

Zymosan Enhances the Mucosal Adjuvant Activity of Poly(I:C) in a Nasal Influenza VaccineAINAI, Akira; ICHINOHE, Takeshi; TAMURA, Shin-Ichi et al.Journal of medical virology. 2010, Vol 82, Num 3, pp 476-484, issn 0146-6615, 9 p.Article

Neonatal immune response and serum bactericidal activity induced by a meningococcal conjugate vaccine is enhanced by LT-K63 and CpG2006BRYNJOLFSSON, Siggeir F; BJARNARSON, Stefania P; MORI, Elena et al.Vaccine. 2008, Vol 26, Num 35, pp 4557-4562, issn 0264-410X, 6 p.Article

Ganglioside GM1-binding peptides as adjuvants of antigens inoculated by the intranasal routeMONTANER, Alejandro D; DE NICHILO, Analfa; ELIAS, Femanda et al.Vaccine. 2006, Vol 24, Num 11, pp 1889-1896, issn 0264-410X, 8 p.Article

Modulation of HIV peptide antigen specific cellular immune response by synthetic α- and β-defensin peptidesMOHAN, Teena; SHARMA, Chandresh; BHAT, Ajaz A et al.Vaccine. 2013, Vol 31, Num 13, pp 1707-1716, issn 0264-410X, 10 p.Article

Intranasal immunization with a mixture of PspA and a Toll-like receptor agonist induces specific antibodies and enhances bacterial clearance in the airways of miceOMA, Keita; JIZI ZHAO; EZOE, Hirokazu et al.Vaccine. 2009, Vol 27, Num 24, pp 3181-3188, issn 0264-410X, 8 p.Article

Oral immunogenicity and protective efficacy in mice of transgenic rice plants producing a vaccine candidate antigen (As 16) of Ascaris suum fused with cholera toxin B subunitMATSUMOTO, Yasunobu; SUZUKI, Seiko; NOZOYE, Tomoko et al.Transgenic research. 2009, Vol 18, Num 2, pp 185-192, issn 0962-8819, 8 p.Article

A new adjuvanted nanoparticle-based H1N1 influenza vaccine induced antigen-specific local mucosal and systemic immune responses after administration into the lungNEUHAUS, Vanessa; CHICHESTER, Jessica A; EBENSEN, Thomas et al.Vaccine. 2014, Vol 32, Num 26, pp 3216-3222, issn 0264-410X, 7 p.Article

Characterization of Stability and Nasal Delivery Systems for Immunization with Nanoemulsion-Based VaccinesMAKIDON, Paul E; NIGAVEKAR, Shraddha S; BIELINSKA, Anna U et al.Journal of aerosol medicine and pulmonary drug delivery. 2010, Vol 23, Num 2, pp 77-89, issn 1941-2711, 13 p.Article

Role of CD80 and CD86 in host immune responses to the recombinant hemagglutinin domain of Porphyromonas gingivalis gingipain and in the adjuvanticity of cholera toxin B and monophosphoryl lipid APING ZHANG; LEWIS, Janina P; MICHALEK, Suzanne M et al.Vaccine. 2007, Vol 25, Num 33, pp 6201-6210, issn 0264-410X, 10 p.Article

DNA-VLP prime-boost intra-nasal immunization induces cellular and humoral anti-HIV-1 systemic and mucosal immunity with cross-clade neutralizing activityBUONAGURO, L; DEVITO, C; TORNESELLO, M. L et al.Vaccine. 2007, Vol 25, Num 32, pp 5968-5977, issn 0264-410X, 10 p.Article

The biology of oral tolerance and issues related to oral vaccine design : Vaccines and immunityPOONAM, Poonam.Current pharmaceutical design. 2007, Vol 13, Num 19, pp 2001-2007, issn 1381-6128, 7 p.Article